About leptospirosis and information: expanding health negligence concepts

Main Article Content

Cláudio Manuel Rodrigues


When quoting the term “negligence” in a public health contextualization, the main inference is that we are neither dealing with lacking of financial resources, nor with available therapeutical management, but facing dissembled diseases, by professional staff which should be responsible for engaging forces to have them mitigated – although representing a potential hazard or an already installed impairment to public health. The laxity of a disease has a dual meaning. First is the mention of a classic oversighting speech due to the main performer’s lack of action: the pharmaceutical industry, the government and its health system. The second, with an intricate and concurrent arrangement, tells about the poor population management, producing a vicious circle that chains, leastwise a billion of souls worldwide. The World Health Organization only identifies 17 diseases called “neglected”, which affects these vulnerable populations both socially and economically. Leptospirosis — an emergent, endemic and globally incidence zoonosis — was not included. Taking the magnification of the “neglected disease” concept as a proposal, we discuss the hegemonic model disruption; taking into consideration how unassisted is leptospirosis as a major global incidence disease with a high lethal coverage, especially in areas without an adequate economical influx, due to the lack of reliable data about this disease and its relationship with animal and human populations.


Download data is not yet available.

Article Details

How to Cite
Rodrigues, C. M. (2017). About leptospirosis and information: expanding health negligence concepts. ABCS Health Sciences, 42(1). https://doi.org/10.7322/abcshs.v42i1.949
Review Articles


1. Wikipédia. A enciclopédia livre. Negligência. Disponível em: http://pt.wikipedia.org/wiki/Neglig%C3%AAncia. Acesso em: 22 abr. 2015.

2. Houaiss A, Villar MS. Dicionário Houaiss de Língua Portuguesa. Rio de Janeiro: Objetiva; 2009.

3. World Health Organization (WHO). First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: WHO; 2010.

4. Araújo IS, Moreira AL, Aguiar R. Doenças negligenciadas, comunicação negligenciada. Apontamentos para uma pauta política e de pesquisa. R Eletr de Com Inf Inov Saúde. 2013;6(4 Suppl. 1). http://dx.doi.org/ 10.3395/reciis.v3i4.329pt

5. Yamey G. Public sector must develop drugs for neglected diseases. BMJ. 2002;324(7339): 698. http://dx.doi.org/10.1136/bmj.324.7339.698/b

6. Morel CM. Inovação em saúde e doenças negligenciadas. Cad Saúde Pública. 2006;22(8): 1522-3.

7. Souza W. Doenças negligenciadas. Rio de Janeiro: Academia Brasileira de Ciências; 2010. 56 p.

8. World Health Organization (WHO). Neglected diseases. Disponível em: https://rarediseases.info.nih.gov/files/neglected_diseases_faqs.pdf. Acesso em: 23 dez. 2014.

9. Albuquerque Filho APL, Araújo JG, Souza IQ, Martins LC, Oliveira MI, Silva MJB, et al. Validation of a case definition for leptospirosis diagnosis in patients with acute severe febrile disease admitted in reference hospitals at the state of Pernambuco, Brazil. Rev Soc Bras Med Trop. 2011;44(6):735-9. http://dx.doi.org/10.1590/S0037-86822011000600016

10. Oliveira EA, Labra ME, Bermudez J. A produção pública de medicamentos no Brasil: uma visão geral. Cad Saúde Pública. 2006;22(11):2379-89. http://dx.doi.org/10.1590/S0102-311X2006001100012

11. Brasil. Ministério da Saúde. Departamento de Ciência e Tecnologia, Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Doenças negligenciadas: estratégias do Ministério da Saúde. Rev Saúde Pública. 2010;44(1):200-2. http://dx.doi.org/10.1590/S0034-89102010000100023

12. Drugs for Neglected Disease initiative (DNDi). 2008-2009 Annual Report. Delivering innovation and building a robust pipeline. Neglected patients. Disponível em: http://www.dndi.org/wp-content/uploads/2009/03/ar2009.pdf. Acesso em: 22 abr. 2015.

13. Elias N. A solidão dos moribundos. Rio de Janeiro: Jorge Zahar; 2001.

14. Schneider MC, Jancloes M, Buss DF, Aldighieri S, Bertherat E, Najera P, et al. Leptospirosis: a silent epidemic disease. Int J Environ Res Public Health. 2013;10(12):7229-34. http://dx.doi.org/10.3390/ijerph10127229

15. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17(4): 494-501. http://dx.doi.org/10.1111/j.1469-0691.2011.03474.x

16. Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5(9):1413-25. http://dx.doi.org/10.2217/fmb.10.102

17. Hotez PJ. A plan to defeat neglected tropical diseases. Sci Am. 009;302(1):90-6.

18. World Health Organization (WHO). Report of the second meeting of the leptospirosis burden epidemiology reference group. Geneva: WHO; 2011.

19. Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Intern J Infect Dis. 2008;12(4):351-7. http://dx.doi.org/10.1016/j.ijid.2007.09.011

20. Durski KN, Jancloes M, Chowdhary T, Bertherat E. A global, multidisciplinary, multi-sectorial initiative to combat leptospirosis: Global Leptospirosis Environmental Action Network (GLEAN). Int J Environ Res Public Health. 2014;11(6):6000-8. http://dx.doi.org/10.3390/ijerph110606000

21. Ribeiro GS. Subdiagnóstico aumenta o risco. Rev Pesquisa Médica. Disponível em: http://www.revistapesquisamedica.com.br/portal/ textos.asp?codigo=11649. Acesso em: 27 dez. 2014.

22. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Leptospirose: diagnóstico e manejo clínico. Brasília: Ministério da Saúde; 2014.

23. Rajeev S, Ilha M, Woldemeskel M, Berghaus RD, Pence ME. Detection of asymptomatic renal Leptospira infection in abattoir slaughtered cattle in southeastern Georgia, United States. SAGE Open Med. 2014;2:1-5. http://dx.doi.org/10.1177/2050312114544696

24. Morel CM, Serruya SJ, Pena GO, Guimarães R. Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases. PLoS Negl Trop Dis. 2009;3(8):e501. http://dx.doi.org/10.1371/journal.pntd.0000501

25. Global Forum for Health Research. The Global Forum Update on Research for Health, v. 3. Combating disease and promoting health: setting the agenda for health research. London: Pro-Brook Publishing; 2006. p. 11-5.

26. World Health Organization (WHO). Report of the second meeting of the leptospirosis burden epidemiology reference group. Geneva:
WHO; 2011.

27. Lima RC. Leptospirose: um estudo epidemiológico e aplicação de medidas preventivas em uma região do município de Belém, Pará. Monografia (Conclusão de Curso) – Universidade Federal do Pará, Belém, 2009. p. 1-66.

28. Brum L, Kupek E. Record linkage and capture-recapture estimates for underreporting of human leptospirosis in a Brazilian health district. Braz J Infect Dis. 2005;9(6):515-20. http://dx.doi.org/10.1590/S1413-86702005000600011

29. Souza VMM, Arsky MLNS, Castro APB, Araujo WN. Anos potenciais de vida perdidos e custos hospitalares da leptospirose no Brasil. Rev Saúde Pública. 2011;45(6):1001-8. http://dx.doi.org/10.1590/S0034-89102011005000070